Home LiteratureArticle Details

PMID: 19465464 Published · epublish English Journal Article

Newer agents for blood glucose control in type 2 diabetes: summary of NICE guidance.

BMJ (Clinical research ed.) ·Vol. 338 ·2009-05-22 ·Pages b1668

Adler AI, Shaw EJ, Stokes T, Ruiz F, Guideline Development Group

Abstract

暂无摘要

MeSH Terms

Blood Glucose Decision Making Diabetes Mellitus, Type 2/drug therapy Dipeptidyl-Peptidase IV Inhibitors/therapeutic use Exenatide Humans Hypoglycemic Agents/therapeutic use Insulin/therapeutic use Peptides/therapeutic use Practice Guidelines as Topic Thiazolidinediones/therapeutic use Venoms/therapeutic use

Chemicals

Blood Glucose Dipeptidyl-Peptidase IV Inhibitors Hypoglycemic Agents Insulin Peptides Thiazolidinediones Venoms Exenatide

Authors & Affiliations

5 authors, click to expand affiliations / ORCID

Adler Amanda I

Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ. [email protected]

Shaw Elizabeth J

Stokes Tim

Ruiz Francis

Guideline Development Group

Investigators

19 investigators, click to expand

Adler Amanda

Allerdyce Claudette

Doherty Tony

Farmer Andrew

Goenka Niru

Hadley-Brown Martin

Home Philip

Ivory Philip

Johns Yvonne

Lewin Ian

McGuire Alistair

Wood Julie

Ayiku Lynda

Banks Emma

Elliott Nicole

Heath Michael

Ruiz Francis

Shaw Elizabeth

Stokes Tim

Article Info

Journal

BMJ (Clinical research ed.)

Abbr.

BMJ

ISSN

1756-1833

DOI

10.1136/bmj.b1668

[email protected]

Published

2009-05-22

Epub

2009-00-22

Pages

b1668

Language

English

Region

England

NLM ID

8900488

Subset

External Links

PubMed source DOI: 10.1136/bmj.b1668 View journal details

Analysis Services

Newer agents for blood glucose control in type 2 diabetes: summary of NICE guidance.

Contact

WeChat Official Account